GoodRx to Present at the Cowen 43rd Annual Health Care Conference
Get Alerts GDRX Hot Sheet
Join SI Premium – FREE
SANTA MONICA, Calif.--(BUSINESS WIRE)-- GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading digital healthcare platform, today announced that executives from the Company will be presenting at the Cowen 43rd Annual Health Care Conference in Boston, MA on Tuesday, March 7, 2023 at 6:50 a.m. Pacific Time (9:50 a.m. Eastern Time).
A live webcast of the presentation will be available on the Company's Investor Relations website, https://investors.goodrx.com/. Following the conference, an archived recording will be available on the Company’s website for at least 30 days.
About GoodRx
GoodRx is a leading digital healthcare platform that makes healthcare affordable and convenient for all Americans. We offer consumers free access to transparent and lower prices for brand and generic medications, affordable and convenient medical provider consultations via telehealth, and comprehensive healthcare research and information. Since 2011, we have helped consumers save over $45 billion and are one of the most downloaded medical apps over the past decade.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230221005713/en/
Investor Contact
GoodRx
Whitney Notaro
[email protected]
Press Contact
GoodRx
Lauren Casparis
[email protected]
Source: GoodRx Holdings, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lark Electric Joins American Gridwork Partners in Strategic Partnership to Accelerate Regional Growth and Expand Industrial Automation Capabilities
- American Gridwork Partners Welcomes Three Additional Companies, Expanding Physical Infrastructure Platform Across the Southeast and Ohio Valley
- ZANVASTRO™ (zilganersen) approved by the FDA as the first and only disease modifying treatment for Alexander disease (AxD) in pediatric and adult patients
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share